Unknown OBSERVATIONAL NCT02699528

The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

Does Methylphenidate, Prescribed for Attention Deficit Disorder, Influence Primary Enuresis in These Children?

Sponsor: Meir Medical Center

Conditions Attention Deficit Hyperactivity Disorder Enuresis

Updated 7 times since 2017 Last updated: Sep 15, 2016 Started: May 31, 2016 Primary completion: Apr 30, 2017 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02699528, this observational or N/A phase trial focuses on Attention Deficit Hyperactivity Disorder and Enuresis and remains ongoing. Sponsored by Meir Medical Center, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Oct 2018 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Oct 2018 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meir Medical Center

Data source: Meir Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kfar Saba, Israel